STOCK TITAN

[Form 4] BioSig Technologies, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Frank Giustra, a director and 10% owner of Streamex Corp. (STEX), reported multiple purchases of the issuer's common stock executed on 07/25/2025 and 08/14/2025. The filings show four purchases on July 25 totaling 50,000 shares at prices between $4.64 and $4.72, and a later purchase on August 14 of 128,205 shares at $3.90, bringing the reported beneficial ownership to 178,205 shares. The shares are held indirectly through Sestini & Co., an entity controlled by the reporting person, as disclosed in the explanation. There are no derivative securities reported on this form. The document is signed by the reporting person on 09/15/2025.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Significant insider purchases increased beneficial holdings to 178,205 shares, all held indirectly through a controlled entity.

The reporting shows concentrated open-market purchases executed in late July and mid-August 2025, cumulatively raising Giustra's beneficial ownership to 178,205 shares. Transaction prices ranged from $3.90 to $4.72, indicating material capital deployed by an insider and suggesting confidence or a strategic accumulation. The ownership is indirect via Sestini & Co., which affects how control and voting might be exercised. No options, warrants or other derivatives are disclosed, so reported exposure is equity-only.

TL;DR: Director disclosed indirect ownership structure and multiple purchases; form is complete regarding reported non-derivative transactions.

The filing cleanly discloses the relationship (Director and 10% owner) and specifies that the shares are held by an entity controlled by the reporting person, satisfying Section 16 transparency on beneficial ownership. Multiple small transactions are aggregated and reported on separate lines, culminating in a single cumulative total. The absence of amendments or derivative holdings simplifies the ownership picture. Signature dated 09/15/2025 is provided, completing the Form 4 submission.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
GIUSTRA FRANK

(Last) (First) (Middle)
17 CHESTER ROW

(Street)
LONDON, X0 SW1W 9JF

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Streamex Corp. [ STEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/25/2025 P 4,975 A $4.64 4,975 I(1) 4,975
Common Stock 07/25/2025 P 11,399 A $4.66 11,399 I(1) 16,374
Common Stock 07/25/2025 P 6,424 A $4.69 6,424 I(1) 22,798
Common Stock 07/25/2025 P 27,202 A $4.72 27,202 I(1) 50,000
Common Stock 08/14/2025 P 128,205 A $3.9 128,205 I(1) 178,205
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The securities reported herein are held by Sestini & Co., an entity controlled by the Reporting Person, and therefore beneficially owned by the Reporting Person.
/s/ Giustra Frank 09/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
BioSig Technologies Inc

NASDAQ:BSGM

BSGM Rankings

BSGM Latest News

BSGM Latest SEC Filings

BSGM Stock Data

156.96M
25.09M
28.73%
28.66%
4.96%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
WESTPORT